Peter Zbinden

1.1k total citations
22 papers, 622 citations indexed

About

Peter Zbinden is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Peter Zbinden has authored 22 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Computational Theory and Mathematics. Recurrent topics in Peter Zbinden's work include Chemical Synthesis and Analysis (6 papers), Computational Drug Discovery Methods (4 papers) and Receptor Mechanisms and Signaling (4 papers). Peter Zbinden is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Computational Drug Discovery Methods (4 papers) and Receptor Mechanisms and Signaling (4 papers). Peter Zbinden collaborates with scholars based in Switzerland, Germany and United States. Peter Zbinden's co-authors include Angelo Vedani, Max Dobler, James P. Snyder, Paulette A. Greenidge, Markus Zollinger, Rolf Pokorny, Michael Seiberling, Gerhard Groß, Hans-Peter Gschwind and Monique Ben‐Am and has published in prestigious journals such as Journal of the American Chemical Society, Drug Discovery Today and Drug Metabolism and Disposition.

In The Last Decade

Peter Zbinden

22 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Zbinden Switzerland 13 283 148 125 124 82 22 622
Carl Crysler United States 19 304 1.1× 325 2.2× 71 0.6× 53 0.4× 64 0.8× 37 782
Michael N. Greco United States 18 432 1.5× 489 3.3× 57 0.5× 29 0.2× 69 0.8× 32 967
Werner Breitenstein Switzerland 13 163 0.6× 146 1.0× 38 0.3× 36 0.3× 32 0.4× 20 387
Surinder S. Narula United States 15 377 1.3× 111 0.8× 107 0.9× 20 0.2× 21 0.3× 25 743
Régis Leung-Toung Canada 18 199 0.7× 519 3.5× 47 0.4× 27 0.2× 35 0.4× 24 827
Harold V. Meyers United States 13 262 0.9× 241 1.6× 65 0.5× 22 0.2× 105 1.3× 20 595
Chu‐Biao Xue United States 22 577 2.0× 320 2.2× 76 0.6× 49 0.4× 8 0.1× 52 1.0k
Darin E. Jones United States 20 297 1.0× 373 2.5× 49 0.4× 30 0.2× 40 0.5× 44 796
Matthias Gehringer Germany 19 807 2.9× 614 4.1× 52 0.4× 186 1.5× 86 1.0× 43 1.4k
Scott I. Klein United States 14 221 0.8× 161 1.1× 122 1.0× 67 0.5× 49 0.6× 19 507

Countries citing papers authored by Peter Zbinden

Since Specialization
Citations

This map shows the geographic impact of Peter Zbinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Zbinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Zbinden more than expected).

Fields of papers citing papers by Peter Zbinden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Zbinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Zbinden. The network helps show where Peter Zbinden may publish in the future.

Co-authorship network of co-authors of Peter Zbinden

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Zbinden. A scholar is included among the top collaborators of Peter Zbinden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Zbinden. Peter Zbinden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ermert, Philipp, Anatol Luther, Peter Zbinden, & Daniel Obrecht. (2019). Frontier Between Cyclic Peptides and Macrocycles. Methods in molecular biology. 2001. 147–202. 10 indexed citations
3.
Zbinden, Peter. (2006). Alpenquerende Tunnel: Prüfsystem für Betonmischungen beim Gotthard‐Basistunnel. Beton- und Stahlbetonbau. 102(1). 11–18. 1 indexed citations
4.
Gschwind, Hans-Peter, Ulrike Pfaar, Felix Waldmeier, et al.. (2005). METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS. Drug Metabolism and Disposition. 33(10). 1503–1512. 186 indexed citations
5.
Topp, Andreas, Peter Zbinden, H. Wehner, & Urs Regenass. (2005). A Novel Storage and Retrieval Concept for Compound Collections on Dry Film. JALA Journal of the Association for Laboratory Automation. 10(2). 88–97. 2 indexed citations
6.
Albrecht, Hugo, Peter Zbinden, Andrea Rizzi, et al.. (2004). High Throughput Screening of β-Amyloid Secretion Inhibitors Using Homogenous Time-Resolved Fluorescence. Combinatorial Chemistry & High Throughput Screening. 7(8). 745–756. 2 indexed citations
7.
Zbinden, Peter, et al.. (2004). The evolution of microarrayed compound screening. Drug Discovery Today. 9(8). 358–365. 20 indexed citations
8.
Vedani, Angelo & Peter Zbinden. (1998). Quasi-atomistic receptor modeling. Pharmaceutica Acta Helvetiae. 73(1). 11–18. 9 indexed citations
9.
Vedani, Angelo, Max Dobler, & Peter Zbinden. (1998). Quasi-Atomistic Receptor Surface Models:  A Bridge between 3-D QSAR and Receptor Modeling. Journal of the American Chemical Society. 120(18). 4471–4477. 35 indexed citations
10.
Zbinden, Peter, Max Dobler, Gerd Folkers, & Angelo Vedani. (1998). PrGen: Pseudoreceptor Modeling Using Receptor-mediated Ligand Alignment and Pharmacophore Equilibration. Quantitative Structure-Activity Relationships. 17(2). 122–130. 40 indexed citations
11.
Vedani, Angelo & Peter Zbinden. (1997). [Target proteins and mechanisms of ochratoxin toxicity. A contribution to the identification of potential ochratoxin antagonists]. PubMed. 14(4). 155–164. 2 indexed citations
12.
Barratt, Martin D., José V. Castell, M. Chamberlain, et al.. (1995). The Integrated Use of Alternative Approaches for Predicting Toxic Hazard. Alternatives to Laboratory Animals. 23(3). 410–429. 27 indexed citations
13.
Vedani, Angelo, Peter Zbinden, James P. Snyder, & Paulette A. Greenidge. (1995). Pseudoreceptor Modeling: The Construction of Three-Dimensional Receptor Surrogates. Journal of the American Chemical Society. 117(17). 4987–4994. 74 indexed citations
14.
Vedani, Angelo, Peter Zbinden, & James P. Snyder. (1993). Pseudo-Receptor Modeling: A new Concept for the Three-Dimensional Construction of Receptor Binding Sites. Journal of Receptor Research. 13(1-4). 163–177. 24 indexed citations
15.
Plattner, Dietmar A., Andreas Brunner, Markus Dobler, et al.. (1993). ChemInform Abstract: Cyclic Oligomers of (R)‐3‐Hydroxybutanoic Acid: Preparation and Structural Aspects.. ChemInform. 24(47). 3 indexed citations
16.
Müller, Hans‐Martin, Max Dobler, Peter Zbinden, & Dieter Seebàch. (1991). Bildung 12- bis 40-gliedriger Oligolide aus enantiomerenreinen 3-Hydroxybuttersäure-Derivaten – Bausteine für eine 2₁- und eine 3₁-Helix. CHIMIA International Journal for Chemistry. 45(12). 376–376. 13 indexed citations
17.
Gerlach, Hans, et al.. (1990). Stereoselektive Synthesen von substituierten Tricarbonyl[tris(methylen)methan]eisen(0)‐Komplexen. Helvetica Chimica Acta. 73(8). 2136–2146. 11 indexed citations
18.
Gerlach, Hans, Peter Zbinden, Max Dobler, et al.. (1989). Optically Active Isoprene(tricarbonyl)iron(0) and Methyltrimethylenemethane(tricarbonyl)iron(0). Angewandte Chemie International Edition in English. 28(12). 1657–1659. 13 indexed citations
19.
Gerlach, Hans, Peter Zbinden, Max Dobler, et al.. (1989). Optisch aktives Isopren(tricarbonyl)eisen(0) und Methyltrimethylenmethan(tricarbonyl)eisen(0). Angewandte Chemie. 101(12). 1744–1745. 12 indexed citations
20.
Glasfeld, Arthur, Peter Zbinden, Max Dobler, Steven A. Benner, & Jack D. Dunitz. (1988). Crystal structures of two simple N-substituted dihydronicotinamides: possible implications for stereoelectronic arguments in enzymology. Journal of the American Chemical Society. 110(15). 5152–5157. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026